Showing results (321-330 of 909) with videos related to
Sort By:
Pageof 91
European Heart Journal|May 1, 2014
Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder StudyGilles Montalescot, Bertram Pitt, Esteban Lopez de Sa, et al.Archives of Internal Medicine|January 26, 2005
The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitusJames R Sowers, William B White, Bertram Pitt, et al.Kidney International|September 17, 2015
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemiaDavid A Bushinsky, Gordon H Williams, Bertram Pitt, et al.Circulation. Heart Failure|July 13, 2018
Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response PatternsJoão Pedro Ferreira, Kevin Duarte, John J V McMurray, et al.Heart (British Cardiac Society)|July 5, 2014
Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptomsDawn Lee, Koo Wilson, Ron Akehurst, et al.European Journal of Heart Failure|September 16, 2025
An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fractionMasatake Kobayashi, Kevin Duarte, João Pedro Ferreira, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 15, 2017
Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of HypertensionCsaba P Kovesdy, Lawrence J Appel, Morgan E Grams, et al.Journal of the American Society of Hypertension : JASH|October 15, 2017
Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of HypertensionCsaba P Kovesdy, Lawrence J Appel, Morgan E Grams, et al.JAMA Network Open|October 26, 2022
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary AnalysisBertram Pitt, Rajiv Agarwal, Stefan D Anker, et al.European Heart Journal. Acute Cardiovascular Care|January 12, 2022
Prognostic relevance of magnesium alterations in patients with a myocardial infarction and left ventricular dysfunction: insights from the EPHESUS trialPieter Martens, João Pedro Ferreira, John Vincent, et al.Pageof 91